Uchiyama Holdings Co Ltd
Uchiyama Holdings Co Ltd has a liquidity position that is currently medium, with a current ratio of 1.62, indicating the company can cover its short-term liabilities with its short-term assets. The company holds JPY 10,758,237,000 in cash and equivalents, but this is offset by long-term debt of JPY 13,637,708,000, resulting in a negative net cash position. This suggests the company may need to rely on operating cash flow or external financing to service its debt obligations. The company's profitability is underperforming relative to industry norms, with a return on equity (ROE) of -1.29% and a return on assets (ROA) of -0.51%. These negative returns indicate that the company is not generating sufficient returns to cover its cost of capital, which is a concern for investors. The operating loss of JPY 294,567,000 and net loss of JPY 158,982,000 further underscore the company's financial challenges. Uchiyama Holdings Co Ltd's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases the company's exposure to sector-specific risks, such as regulatory changes or shifts in demand for biotechnology services. The company's growth trajectory is uncertain, with no clear indication of revenue growth in the current fiscal year. The operating cash flow of JPY 2,002,765,000 is a positive sign, but it is not sufficient to offset the net loss or the capital expenditure of JPY 896,404,000. The company's capital structure is heavily leveraged, with a debt-to-equity ratio of 1.1, which increases financial risk and may limit its ability to invest in growth opportunities. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's negative net cash position is a key flag, suggesting potential liquidity constraints. However, the low dilution risk implies that the company is not currently issuing new shares at a rate that would significantly dilute existing shareholders. The company's recent financial performance and capital structure suggest that it may need to manage its debt more effectively to improve its financial health. Recent events, including the company's financial performance and capital structure, have been disclosed in its latest financial statements. The company's operating cash flow and capital expenditure figures indicate that it is investing in its operations, but the net loss and negative ROE suggest that these investments are not yet generating returns. The company's management will need to address these issues to improve its financial performance and reduce its financial risk.
Business. Uchiyama Holdings Co Ltd operates in the healthcare facilities and services industry, providing biotechnology-related services and equipment.
Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a high confidence level of 0.92.
- Uchiyama Holdings Co Ltd is experiencing negative returns on equity and assets, indicating poor profitability.
- The company has a negative net cash position, which increases liquidity risk.
- Revenue is concentrated in a single business segment, increasing exposure to sector-specific risks.
- The company's debt-to-equity ratio is 1.1, indicating a leveraged capital structure.
- Operating cash flow is positive but insufficient to offset the net loss and capital expenditure.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.